Sucampo Pharmaceuticals (SCMP) Crumbles: Stock Falls by 6.3% - Tale of the Tape


Shutterstock photo

Sucampo Pharmaceuticals, Inc. ( SCMP ) saw a big move last session, as the company's shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for SCMP, as the stock is now up 0.5% in the past one-month time frame.

This medical drugs company has seen a flat record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases). The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

SCMP currently has a Zacks Rank #3 (Hold) while it has an Earnings ESP of 0.00%.

Investors interested in the medical drugs industry may consider better-ranked stocks like Endocyte, Inc. ( ECYT ), Forest Laboratories Inc. ( FRX ) and WuXi PharmaTech (Cayman) Inc. ( WX ). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

SUCAMPO PHARMAC (SCMP): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by